Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Total Current Liabilities (2018 - 2025)

Historic Total Current Liabilities for Revolution Medicines (RVMD) over the last 8 years, with Q3 2025 value amounting to $245.6 million.

  • Revolution Medicines' Total Current Liabilities rose 12155.45% to $245.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.6 million, marking a year-over-year increase of 12155.45%. This contributed to the annual value of $163.9 million for FY2024, which is 1394.71% up from last year.
  • Per Revolution Medicines' latest filing, its Total Current Liabilities stood at $245.6 million for Q3 2025, which was up 12155.45% from $184.5 million recorded in Q2 2025.
  • Over the past 5 years, Revolution Medicines' Total Current Liabilities peaked at $245.6 million during Q3 2025, and registered a low of $43.8 million during Q1 2021.
  • In the last 5 years, Revolution Medicines' Total Current Liabilities had a median value of $78.1 million in 2023 and averaged $99.1 million.
  • Over the last 5 years, Revolution Medicines' Total Current Liabilities had its largest YoY gain of 13207.76% in 2023, and its largest YoY loss of 491.32% in 2023.
  • Revolution Medicines' Total Current Liabilities (Quarter) stood at $60.4 million in 2021, then rose by 2.71% to $62.0 million in 2022, then skyrocketed by 132.08% to $143.9 million in 2023, then grew by 13.95% to $163.9 million in 2024, then skyrocketed by 49.85% to $245.6 million in 2025.
  • Its Total Current Liabilities stands at $245.6 million for Q3 2025, versus $184.5 million for Q2 2025 and $158.6 million for Q1 2025.